Sunday, March 29, 2009

Updates sent to Twitter, March 22-28

Updates about CSC sent to Twitter during the fourth week of March:

Understanding the cancer stem cell hypothesis, Portal (OICR Newsletter) Winter 2009 [March 27]:
[Full text is publicly accessible].

Stem-cell driven cancer: "Hands-off" regulation of cancer development [OA][March 26]:
[Full text is openly accessible].

MicroRNA-199b-5p Impairs Cancer Stem Cells through Negative Regulation of HES1 in Medulloblastoma [OA][March 26]:
[Full text is openly accessible].

Making Connections between Stem Cells and Cancer, NCI Director's Update, Mar. 24, 2009 [March 25]:
[Full text is publicly accessible].

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits [March 25]:
[Full text is publicly accessible (free registration is required)].

Nuclear signalling by tumour-associated antigen EpCAM (reference 1 in Micromet news item [see below]) [March 24]:

Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients [March 24]:
[Full text is publicly accessible].

Oncolytic reovirus effectively targets breast cancer stem cells, Mol Ther 2009(Mar 17) [March 23]:

Pancreatic cancer stem cells and relevance to cancer treatments, J Cell Biochem 2009(Mar 19) [March 23]:

1 comment:

  1. There is a group of physicians, patients and other interested people working together to get treatment with adult stem cells legalized in the U.S. as it should be. Please ask your family and friends to sign up ("JOIN"), and get as many doctors to sign up as well. Please see The American Stem Cell Therapy Association site